The short version of lipolysis fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-12-07. Anything still debated is marked as such rather than presented as settled.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Status varies by country; prohibited in sport. |
| Common storage temperature | 2–8 °C for lyophilized powder | Protect from light and moisture; follow supplier instructions. |
| Typical analytical method | LC-MS/MS | Used for identification and quantification in biological samples. |
| Purity assessment | HPLC and mass spectrometry | Reverse-phase HPLC is common for peptide purity. |
| Common synonyms | AOD9604; hGH 176-191 fragment | Naming conventions differ across studies. |
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
In 1968, Culp also made an uncredited cameo appearance as an inebriated Turkish waiter on Get Smart, the spy-spoof comedy series, in an I Spy parody episode titled "Die Spy". In this, secret agent Maxwell Smart played by Don Adams in effect assumes Culp's Kelly Robinson character, as he pretends to be an international table-tennis champion. The episode faithfully recreates the I Spy theme music, montage graphics, and back-and-forth banter between Robinson and Scott, with actor/comedian Stu Gilliam imitating Cosby. In 1971, Culp, Peter Falk, Robert Wagner, and Darren McGavin each stepped in to take turns with Anthony Franciosa's rotation of NBC's series The Name of the Game after Franciosa was fired, alternating a lead role of the lavish, 90-minute show about the magazine business with Gene Barry and Robert Stack. Also in 1971, he portrayed an unemployed actor, the husband of ambitious Angie Dickinson, in the TV movie See the Man Run. Culp played the murderer in three Columbo episodes ("Death Lends a Hand" in 1971, "The Most Crucial Game" in 1972, "Double Exposure" in 1973) and also appeared in the 1990 episode "Columbo Goes to College" as the father of one of two young murderers. He also played the murderer in the pilot episode of Mrs. Columbo starring Kate Mulgrew in the title role. In 1973, Culp almost took the male lead in the sci-fi television series Space: 1999. During negotiations with creator and executive producer Gerry Anderson, Culp expressed himself to be not only an asset as an actor, but also as a director and producer for the proposed series.
=== GPT === Generative pre-trained transformers (GPTs) are large language models (LLMs) that generate text based on the semantic relationships between words in sentences. Text-based GPT models are pre-trained on a large corpus of text that can be from the Internet. The pretraining consists of predicting the next token (a token being usually a word, subword, or punctuation). Throughout this pretraining, GPT models accumulate knowledge about the world and can then generate human-like text by repeatedly predicting the next token. Typically, a subsequent training phase makes the model more truthful, useful, and harmless, usually with a technique called reinforcement learning from human feedback (RLHF). Current GPT models are prone to generating falsehoods called "hallucinations". These can be reduced with RLHF and quality data, but the problem has been getting worse for reasoning systems. Such systems are used in chatbots, which allow people to ask a question or request a task in simple text. Current models and services include ChatGPT, Claude, Gemini, Copilot, and Meta AI. Multimodal GPT models can process different types of data (modalities) such as images, videos, sound, and text.
A study on the age of the carbonate thin layers covering or underlying rock art from the Cave of Altamira (Spain), providing evidence of several periods of cave art from the ceiling of the studied cave, is published by Pons-Branchu et al. (2026). Evidence from the Velika Pećina, Velika Vranovica and Pećina kod Stene cave sites (Serbia), indicative of human presence in central Balkans during the Last Glacial Maximum, is presented by Kuhn et al. (2026). Masojć et al. (2026) describe a Late Pleistocene human tooth from the Khutul Usny Cave site, representing the first fossil of an early Homo sapiens in Mongolia with secure geological context and providing evidence of presence of the species in southern Mongolia around the onset of the Last Glacial Maximum. A study on the frontal and mandibular morphology of the Red Deer Cave people, interpreted as consistent of affinities with Homo sapiens and indicative of diversity cranial morphology of late Pleistocene hominins from eastern Asia, is published by Fan et al. (2026). Evidence indicating that Solutrean artifacts from the Peña Capón rock shelter (Muriel-Tamajón, Spain) were sourced 600 to 700 kilometers away from this site, in the present-day territory of southwest France, is presented by Sánchez de la Torre et al. (2026). Nash et al. (2026) report rediscovery of putative Upper Paleolithic cave art from the Bacon Hole site (Wales, United Kingdom) originally discovered by William Sollas and Henri Breuil in 1912 and support the interpretation of the studied horizontal lines as cave art. Reiche et al.
=== Lifestyle === A high-stress lifestyle causes an increase in the level of catecholamines, which have also been associated with the development of cellulite. Inactivity can cause vascular stasis, forming cellulite. Excessive carbohydrate consumption may also be related to cellulite in some instances.
The genealogy of lifting can be traced back to the beginning of recorded history where humanity's fascination with physical abilities can be found among numerous ancient writings. In many prehistoric tribes, they would have a big rock they would try to lift, and the first one to lift it would inscribe their name into the stone. Such rocks have been found in Greek and Scottish castles. Progressive resistance training dates back at least to Ancient Greece, when legend has it that wrestler Milo of Croton trained by carrying a newborn calf on his back every day until it was fully grown. Another Greek, the physician Galen, described strength training exercises using the halteres (an early form of dumbbell) in the 2nd century. Ancient Greek sculptures also depict lifting feats. The weights were generally stones, but later gave way to dumbbells. The dumbbell was joined by the barbell in the later half of the 19th century. Early barbells had hollow globes that could be filled with sand or lead shot, but by the end of the century these were replaced by the plate-loading barbell commonly used today. Weightlifting was first introduced in the Olympics in the 1896 Athens Olympic Games as a part of track and field, and was officially recognized as its own event in 1914. The 1960s saw the gradual introduction of exercise machines into the still-rare strength training gyms of the time. Weight training became increasingly popular in the 1970s, following the release of the bodybuilding movie Pumping Iron, and the subsequent popularity of Arnold Schwarzenegger.
Sources: en.wikipedia.org
==== Compilations ==== "Bee Sting" - The Thing That Ate Floyd - (Lookout! Records, 1988) "We Walk" - Surprise Your Pig - A Tribute to R.E.M. - (Staple Gun Records, 1992) "Chemical Warfare" - Virus 100 - (Alternative Tentacles, 1992) "Down All the Days" - The Mission District: 17 Reasons - 7" Box (Mission Merchants, 1992) "Kung Fu Love" - Milk for Pussy - (Mad Queen Records, 1993) "Froggie Would a Wooing Go" - Power Flush - as "Mud Bath" with Mudwimmin - (Broken Rekids, 1993) "The Seventh Hour of the Seventh Day" - Smitten - A Love Song Compilation - (Karate Brand Records, 1994) "A Washed Out Monkey Star Halo" - Dope-Guns-'N-Fucking In The Streets Volume Ten - (Amphetamine Reptile Records, 1994) "The 500 Club" - CMJ New Music August - Volume 24 - (College Music Journal, 1995) "Twist" - Introducing Vol. 2 - (Indigo, 1995) "Twist" - London Records (London Records, 1995) "The Charm" - Jabberjaw... Pure Sweet Hell - (Mammoth, 1996) "The Ghost" - Twisted Willie - (Justice Records, 1996) "A Washed Out Monkey Star Halo" - Dope-Guns-'N-Fucking In The Streets Volumes 8-11 - (Amphetamine Reptile Records, 1997) "Soul Cannon" - Live at Emo's BOX SET - 7" Box (No Lie Music, 1997) "I Dreamed I Dream" - Confuse Yr Idols (A Tribute To Sonic Youth) (Narnack Records, 2004)
=== Medications === The antifibrotics pirfenidone and nintedanib have been shown to slow the decline in lung function (as measured by forced vital capacity [FVC]) in those with ILD compared to placebo. Pirfenidone was associated with a 45% less decline in FVC at 52 weeks compared to placebo in a trial involving people with idiopathic pulmonary fibrosis, and was associated with a slower FVC decline in those with progressive pulmonary fibrosis. Nintedanib was also associated with a slower FVC decline and increased mean survival in people with ILD. The immunomodulator tocilizumab has a benefit in scleroderma associated ILD by helping to preserve lung function (as measured by FVC) at 48 weeks. The immunomodulators cyclophosphamide, mycophenolate mofetil and rituximab all showed improved lung function (as measured by % predicted FVC) compared to placebo in systemic sclerosis or scleroderma associated ILD. The inhaled vasodilator treprostinil (a synthetic prostacyclin which acts as a prostaglandin I2 analogue) is indicated in the treatment of pulmonary hypertension secondary to interstitial lung disease and is associated with improved exercise capacity as measured by a 6-minute walk test.
== Importance of substrate-level phosphorylation in anoxia == During anoxia, provision of ATP by substrate-level phosphorylation in the matrix is important not only as a mere means of energy, but also to prevent mitochondria from straining glycolytic ATP reserves by maintaining the adenine nucleotide translocator in ‘forward mode’ carrying ATP towards the cytosol.
==== Astrocytes and blood oxygen levels ==== The Sur lab has discovered novel and critical roles for astrocytes in brain function. By high resolution imaging in the intact visual cortex, they showed that astrocytes have tuned calcium responses to visual stimuli that are mediated importantly via glutamate transporters on astrocyte processes that surround synapses, and they influence local blood flow and hence the hemodynamic signals that underlie brain imaging methods such as fMRI. Role of astrocytes in information processing and plasticity Astrocytes are also activated by neuromodulators such as acetylcholine and norepinephrine, and Sur and coworkers showed that cholinergic inputs to cortex act via astrocytes to alter the strength of excitatory synapses and implement plasticity of neuronal responses. Furthermore, astrocyte GABA transporters regulate extrasynaptic GABA and influence population coding of visual information by V1 neurons. Astrocyte calcium signaling influences excitatory drive to inhibitory neurons, thereby enabling astrocytes to modulate excitatory-inhibitory balance in neuronal V1 circuits. Astrocytes and learning Glutamate transporters on astrocytes regulate developmental plasticity in visual cortex. Gene expression (of glutamate and GABA transporters) in cortical astrocytes is modulated by learning, and astrocytes thus crucially shape cortical neuronal activity underlying learned behavior.
with two different fluorophores and the antibiotic levofloxacin, showcasing the potential of covalently functionalized recombinant spider silk proteins as biomaterials with enhanced properties. The researchers were able to successfully conjugate
Sources: en.wikipedia.org
Intarcia Therapeutics is an American biopharmaceutical company based in Boston, MA and incorporated under the laws of Delaware. It was founded in 1995 under the name "BioMedicines" and changed to its present name in 2004. In 2013, Intarcia relocated its headquarters to Boston, keeping its manufacturing facility in Hayward, CA. In addition to Boston and Hayward, Intarcia also has a location in Research Triangle Park, North Carolina, where it discovers and develops peptides for its drug delivery system. In 2005, the executive leadership of Intarcia was largely vested in two people, Karling Leung and James Ahlers, President/CEO/Director and Vice President/CFO/Finance & Operations Officer, respectively. By 2012, Kurt Graves had replaced Karling Leung as President and CEO. Kurt Graves has been with Intarcia since August 2010, first serving as Executive Chairman before becoming President and CEO in April 2012. As of 2016, Intarcia is engaged in development of a "potential once-a-year type 2 diabetes treatment". Referred to as ITCA 650, the therapeutic consists of exenatide delivered via its Medici Drug Delivery System, "a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides". The drug was rejected for FDA approval in 2017 and 2020.
== List of leaders == The ILEA was formally created in 1964 and began operations in 1965, but the post of Leader did not exist until April 1967. For the period 1964–67, the de facto leadership was shared between the Chairman of the Education Committee, James Young, and the Chairmen of the Authority, Harold Shearman (1964–1965) and Ashley Bramall (1965–1967). From 1967, the Leaders of the ILEA were:
== Sports == A 2017 INSEE study reported persistent gender disparities in physical and sports activities. Women were underrepresented in racket and team sports. In media coverage, women's sports accounted for less than 20% of televised sports airtime. Leadership roles in sports organizations remain limited for women. Despite the 2014 law for real gender equality, in 2019 only one Olympic sports federation and eleven non-Olympic federations were led by women.
In February 2023, French Foreign Minister Catherine Colonna met with President Lula and stated that "Brazil is one of the main actors on the global stage and its comeback is highly expected", highlighting that France and Brazil share a strong, centuries-old relationship. She also said that France supports a Brazilian OECD membership and that both France and the European Union are considering monetary contributions to the Amazon Fund. On 11 February, French president Emmanuel Macron expressed his approval for a peace plan on the Russia-Ukraine war proposed by Lula, which consists of creating a group of countries not involved in the conflict (either directly or indirectly, i.e. by sending weapons to one of the sides) to mediate a peace process. On 3 June 2023, Macron's office said Lula confirmed he would visit Paris in late June as part of the "Summit for a New Global Financial Pact" promoted by France to "tackle the reform of multilateral development banks (MDB), the debt crisis, financing for green technologies, the creation of new international taxes and financing instruments", among other things. On 22 June, president Lula delivered a speech during the Power Our Planet festival in Paris in which he said "actually, those who have polluted the planet over the last two centuries are the same ones who made the Industrial Revolution, and that's why they must pay their debt to the planet Earth" while calling for climate justice to Latin-American, African and Asian peoples and inviting the world to attend the COP30 climate conference in the Brazilian city of Belém.
== Medical uses == In the US, bempedoic acid is indicated for the treatment of hypercholesterolemia in combination with diet and the highest tolerated statin therapy in adults with heterozygous familial hypercholesterolemia, or with established atherosclerotic cardiovascular disease, who need additional lowering of LDL cholesterol. In the EU, bempedoic acid is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non familial) or mixed dyslipidaemia, as an adjunct to diet in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach LDL-C goals with the maximum tolerated dose of a statin; or alone or in combination with other lipid-lowering therapies in patients who are statin intolerant, or for whom a statin is contraindicated. Evidence for primary prevention is limited. A secondary analysis from the largest trial showed the potential for benefit in primary prevention; however, the number of individuals was small, and all participants were at high risk for ASCVD.
Sources: en.wikipedia.org
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.
The World Anti-Doping Agency classifies growth hormone fragments, including AOD-9604, as prohibited substances. The classification reflects concern about potential performance-enhancing use. Athletes are subject to testing for such peptides.
Detection typically uses liquid chromatography combined with mass spectrometry. These methods separate the peptide and identify it by mass. Immunoassays may screen samples but require confirmation by a more specific technique.
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.